Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood

Journal of Chromatography A

Volumn 1381, Issue , 2015, Pages 87-100

  Steuer, Andrea E ^a   Poetzsch, Michael ^a   Koenig, Magdalena ^a   Tingelhoff, Eva ^a   Staeheli, Sandra N ^a   Roemmelt, Andreas T ^a   Kraemer, Thomas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antidepressants; Comparison; Microflow LC MS MS; Neuroleptics; Validation

Indexed keywords

BLOOD; FORENSIC SCIENCE; LIQUIDS; MASS SPECTROMETRY; MATRIX ALGEBRA; METABOLITES;

ANTIDEPRESSANTS; COMPARISON; LC-MS/MS; NEUROLEPTICS; VALIDATION;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

AGOMELATINE; AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CHLORPROTHIXENE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; DOXEPIN; DRUG METABOLITE; DULOXETINE; FLUOXETINE; FLUPENTIXOL; HALOPERIDOL; IMIPRAMINE; LEVOMEPROMAZINE; MIRTAZAPINE; NEUROLEPTIC AGENT; NORCLOMIPRAMINE; NORCLOZAPINE; NORFLUOXETINE; NORTRIPTYLINE; OLANZAPINE; OPIPRAMOL; PERAZINE; PIPAMPERONE; RADAFAXINE; UNINDEXED DRUG;

ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; HUMAN; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MASS SPECTROMETER; MICROFLOW LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; PRECIPITATION; BLOOD; COMPARATIVE STUDY; FORENSIC TOXICOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CALIBRATION; CHROMATOGRAPHY, LIQUID; FORENSIC TOXICOLOGY; HUMANS; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84922767730     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.12.084     Document Type: Article

References (43)

1. Wang H., Bennett P. Performance assessment of microflow LC combined with high-resolution MS in bioanalysis. Bioanalysis 2013, 5:1249-1267.
2. Christianson C.C., Johnson C.J., Needham S.R. The advantages of microflow LC-MS/MS compared with conventional HPLC-MS/MS for the analysis of methotrexate from human plasma. Bioanalysis 2013, 5:1387-1396.
3. He X., Kozak M., Nimkar S. Ultra-sensitive measurements of 11-Nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid by microflow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer. Anal. Chem. 2012, 84:7643-7647.
4. Duan X., Weinstock-Guttman B., Wang H., Bang E., Li J., Ramanathan M., Qu J. Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. Anal. Chem. 2010, 82:2488-2497.
5. Concheiro M., Lee D., Lendoiro E., Huestis M.A. Simultaneous quantification of Delta(9)-tetrahydrocannabinol 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry. J. Chromatogr. A 2013, 1297:123-130.
6. Kraemer T., Paul L. Bioanalytical procedures for determination of drugs of abuse in blood. Anal. Bioanal. Chem. 2007, 388:1415-1435.
7. Maurer H.H. Mass spectrometric approaches in impaired driving toxicology (review). Anal. Bioanal. Chem. 2009, 393:97-107.
8. Musshoff F., Trafkowski J., Kuepper U., Madea B. An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites. J. Mass Spectrom. 2006, 41:633-640.
9. Maurer H.H. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin. Biochem. 2005, 38:310-318.
10. Fernandez Mdel M., Wille S.M., Kummer N., Di Fazio V., Ruyssinckx E., Samyn N. Quantitative analysis of 26 opioids, cocaine, and their metabolites in human blood by ultra performance liquid chromatography-tandem mass spectrometry. Ther. Drug Monit. 2013, 35:510-521.
11. Bjork M.K., Nielsen M.K., Markussen L.O., Klinke H.B., Linnet K. Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2010, 396:2393-2401.
12. Bjork M.K., Simonsen K.W., Andersen D.W., Dalsgaard P.W., Sigurethardottir S.R., Linnet K., Rasmussen B.S. Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2013, 405:2607-2617.
13. Simonsen K.W., Hermansson S., Steentoft A., Linnet K. A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction and ultra-performance liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2010, 34:332-341.
14. Dussy F.E., Hamberg C., Briellmann T.A. Quantification of benzodiazepines in whole blood and serum. Int. J. Legal Med. 2006, 120:323-330.
15. Patteet L., Maudens K.E., Sabbe B., Morrens M., De Doncker M., Neels H. High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry. Clin. Chim. Acta 2014, 429:51-58.
16. Remane D., Meyer M.R., Peters F.T., Wissenbach D.K., Maurer H.H. Fast and simple procedure for liquid-liquid extraction of 136 analytes from different drug classes for development of a liquid chromatographic-tandem mass spectrometric quantification method in human blood plasma. Anal. Bioanal. Chem. 2010, 397:2303-2314.
17. Saar E., Gerostamoulos D., Drummer O.H., Beyer J. Comparison of extraction efficiencies and LC-MS-MS matrix effects using LLE and SPE methods for 19 antipsychotics in human blood. Anal. Bioanal. Chem. 2009, 393:727-734.
18. Fisher D.S., Partridge S.J., Handley S.A., Couchman L., Morgan P.E., Flanagan R.J. LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Sci. Int. 2013, 229:145-150.
19. Amundsen I., Oiestad A.M., Ekeberg D., Kristoffersen L. Quantitative determination of fifteen basic pharmaceuticals in ante- and post-mortem whole blood by high pH mobile phase reversed phase ultra high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2013, 927:112-123.
20. Montenarh D., Wernet M.P., Hopf M., Maurer H.H., Schmidt P.H., Ewald A.H. Quantification of 33 antidepressants by LC-MS/MS-comparative validation in whole blood, plasma, and serum. Anal. Bioanal. Chem. 2014, 406(24):5939-5953. 10.1007/s00216-014-8019-x.
21. Castaing N., Titier K., Receveur-Daurel M., Le Deodic M., Le Bars D., Moore N., Molimard M. Quantification of eight new antidepressants and five of their active metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2007, 31:334-341.
22. Titier K., Castaing N., Le Deodic M., Le bars D., Moore N., Molimard M. Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole blood. J. Anal. Toxicol. 2007, 31:200-207.
23. Kirchherr H., Kuhn-Velten W.N. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2006, 843:100-113.
24. Peters F.T., Hartung M., Herbold M., Schmitt G., Daldrup T., Musshoff F. Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. Anforderungen an die Validierung von Analysenmethoden. Toxichem. Krimtech. 2009, 76:185.
25. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
26. Communities E. COMMISSION DECISION of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Commun. 2002, L221:8-36.
27. Maurer H.H., Pfleger K., Weber A.A. Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites 2011, Wiley-VCH, Weinheim.
28. Black S.B., Stenhouse A.M., Hansson R.C. Solid-phase extraction and derivatisation methods for beta-blockers in human post mortem whole blood, urine and equine urine. J. Chromatogr. B 1996, 685:67-80.
29. Franke J.P., de-Zeeuw R.A. Solid-phase extraction procedures in systematic toxicological analysis (review). J. Chromatogr. B 1998, 713:51-59.
30. Remane D., Meyer M., Peters F., Wissenbach D., Maurer H. Fast and simple procedure for liquid-liquid extraction of 136 analytes from different drug classes for development of a liquid chromatographic-tandem mass spectrometric quantification method in human blood plasma. Anal. Bioanal. Chem. 2010, 397:2303-2314.
31. Bonfiglio R., King R.C., Olah T.V., Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 1999, 13:1175-1185.
32. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Pharm. Res. 1992, 9:588-592.
33. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., Yacobi A. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 2000, 17:1551-1557.
34. Lindner W., Wainer I.W. Requirements for initial assay validation and publication in J. Chromatography B (editorial). J. Chromatogr. B 1998, 707:1-2.
35. Wayne, PA, 1999.
36. Peters F.T., Maurer H.H. Bioanalytical method validation and its implications for forensic and clinical toxicology - a review. Accredit. Qual. Assur. 2002, 7:441-449.
37. Sedgwick G.W., Fenton T.W., Thompson J.R. Effect of protein precipitating agents on the recovery of plasma-free amino-acids. Can. J. Anim. Sci. 1991, 71:953-957.
38. Remane D., Wissenbach D.K., Meyer M.R., Maurer H.H. Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotope-labeled internal standards by their native analogues using atmospheric-pressure chemical ionization and electrospray ionization and the relevance for multi-analyte liquid chromatographic/mass spectrometric procedures. Rapid Commun. Mass Spectrom. 2010, 24:859-867.
39. Remane D., Meyer M.R., Wissenbach D.K., Maurer H.H. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization. Rapid Commun. Mass Spectrom. 2010, 24:3103-3108.
40. Saar E., Gerostamoulos D., Drummer O.H., Beyer J. Identification of 2-hydroxymethyl-olanzapine as a novel degradation product of olanzapine. Forensic Sci. Int. 2012, 220:74-79.
41. Nielsen M.K., Johansen S.S. Determination of olanzapine in whole blood using simple protein precipitation and liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2009, 33:212-217.
42. Schulz M., Iwersen-Bergmann S., Andresen H., Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit. Care 2012, 16:R136.
43. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2008, Chemical Toxicology Institute, Foster City, CA.